Filing metadata

Accession number
0001127602-20-030923
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Dec 08, 2020
Reporting period
Dec 04, 2020
Description
Insider transaction

Explore SEC Filings Hub